Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.

Thirty patients infected predominantly by Serratia marcescens and Pseudomonas aeruginosa were treated in an open trial with moxalactam, a broad-spectrum beta-lactam antibiotic. Twenty-three (76%) had a satisfactory microbiological or clinical response. Among 25 patients for whom serum inhibitory con...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Platt, R, Ehrlich, S L, Afarian, J, O'Brien, T F, Pennington, J E, Kass, E H
Format: Artigo
Langue:Inglês
Publié: 1981
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC181699/
https://ncbi.nlm.nih.gov/pubmed/6458233
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires